Effects of empagliflozin on functional capacity, LV filling pressure, and cardiac reserves in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction: a randomized controlled open-label trial
Authors
Ф. Т. Агеев (ORCID: https://orcid.org/0000-0003-4369-1393)
А. В. Потехина (ORCID: https://orcid.org/0000-0001-9290-9884)
А. Г. Овчинников (ORCID: https://orcid.org/0000-0003-3285-6148)
Effects of empagliflozin on functional capacity, LV filling pressure, and cardiac reserves in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction: a randomized controlled open-label trial
Ф. Т. Агеев, А. В. Потехина, А. Г. Овчинников, Evgeny Belyavskiy et al.
Citations
7 citations
Journal
Cardiovascular Diabetology
Topics
Diabetes Treatment and Management
Field-Weighted Citation Impact (FWCI)
9.06
article
Effects of empagliflozin on functional capacity, LV filling pressure, and cardiac reserves in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction: a randomized controlled open-label trial
Ф. Т. Агеев, А. В. Потехина, А. Г. Овчинников, Evgeny Belyavskiy, A. Yu. Filatova, O. N. Svirida, Kristina Zherebchikova
article en
7 citations
Abstract
No abstract available for this paper.
Publication Tag
Cardiovascular DiabetologyVol. 24(1)
Institutions
Sechenov University (RU), Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer (DE), National Medical Research Center of Cardiology (RU)